How to Register

Efficacy and Safety of Risedronate in Osteoporosis Subjects with Comorbid Diabetes, Hypertension, and/or Dyslipidemia: A Post Hoc Analysis of Phase III Trials Conducted in Japan

CALCIFIED TISSUE INTERNATIONAL Volume 98 Issue 2 Page 114-122 published_at 2016-02

アクセス数 : 963 件

ダウンロード数 : 0 件

今月のアクセス数 : 40 件

今月のダウンロード数 : 0 件

この文献の参照には次のURLをご利用ください : https://ir.lib.shimane-u.ac.jp/53563

Title	Efficacy and Safety of Risedronate in Osteoporosis Subjects with Comorbid Diabetes, Hypertension, and/or Dyslipidemia: A Post Hoc Analysis of Phase III Trials Conducted in Japan
Creator	Inoue Daisuke Muraoka Ryoichi Okazaki Ryo Nishizawa Yoshiki Sugimoto Toshitsugu
Source Title	CALCIFIED TISSUE INTERNATIONAL
Volume	98
Issue	2
Start Page	114
End Page	122
Journal Identifire	ISSN 0171-967X EISSN 1432-0827
Subjects	Bisphosphonate; Risedronate; Metabolic syndrome; Life style-related disease; Bone mineral density; Bone turnover markers ( Other)
Language	eng
Resource Type	journal article
Publisher	SPRINGER
Date of Issued	2016-02
Access Rights	metadata only access
Relation	[DOI] 10.1007/s00223-015-0071-9 [PMID] 26466937
Remark	This study was supported by the Joint Development Program of Ajinomoto Pharmaceuticals Co., Ltd. and Takeda Pharmaceutical Co., Ltd. Funding for writing/editorial support was provided by Ajinomoto Pharmaceuticals Co., Ltd.